MABQI

Mabqi is a biotechnology company focused on the discovery and development of fully human antibodies. Leveraging an innovative platform, we specialize in uncovering monoclonal antibodies (mAbs), antibody-drug conjugates (ADCs), pH-sensitive antibodies, and various other immunotherapy formats... Mabqi is building a robust pipeline of innovative therapeutic antibodies in oncology. Some of our lead candidates have unique pH-sensitive features and are readily convertible to next generation formats such as ADC, T-cell engagers (TCE), CAR-T therapies.

Also known as: Mabqi SAS

Primary location: Grabels France